Concepedia

Andrew J. Lickteig

AJ

Statistics

Publications

16

Citations

1.1K

H-Index

14

Active since

2006

Affiliations

University of Kansas Medical Center(Current)

University of Arizona

Children's Mercy Hospital

Tianjin University

Institute of Pharmacology

Andrew J. Lickteig is an author at University of Kansas Medical Center specializing in biochemistry, liver disease, and hepatic pathophysiology.

ORCID

Publications per year

2006–2020

16

Publications

16

Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease

Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine et al. · Drug Metabolism and Disposition · 2009 · 347 citations · Full text

, , +17

Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats

Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine et al. · European Journal of Pharmacology · 2009 · 114 citations · Full text

, , +12

Efflux Transporter Expression and Acetaminophen Metabolite Excretion Are Altered in Rodent Models of Nonalcoholic Fatty Liver Disease

Andrew J. Lickteig, Craig D. Fisher, Lisa M. Augustine et al. · Drug Metabolism and Disposition · 2007 · 98 citations

, , +17

Intestine-Specific Deletion of SIRT1 in Mice Impairs DCoH2–HNF-1α–FXR Signaling and Alters Systemic Bile Acid Homeostasis

Nevzat Kazgan, Mallikarjuna R. Metukuri, Aparna Purushotham et al. · Gastroenterology · 2014 · 76 citations · Full text

, , +14

Tissue distribution, ontogeny and induction of the transporters Multidrug and toxin extrusion (MATE) 1 and MATE2 mRNA expression levels in mice

Andrew J. Lickteig, Xingguo Cheng, Lisa M. Augustine et al. · Life Sciences · 2008 · 70 citations · Full text

, , +12

1–5 of 16